or Try an Advanced Search...

    Adoptive Cell Transfer Stocks List

    Symbol Grade Name % Change
    IOVA D Iovance Biotherapeutics, Inc. -1.82
    IMTX D Immatics N.V. 1.39
    CLLS B Cellectis S.A. -1.64
    CERO F CERo Therapeutics Holdings, Inc. 0.00
    ALLO F Allogene Therapeutics, Inc. -7.97
    ADAP D Adaptimmune Therapeutics plc -7.50
    ACET F Adicet Bio, Inc. 1.91
    View As Page of Charts
    Related Industries: Biotechnology Other
    Related Stock Lists: Cancer Medicine Biopharmaceutical Cancer Immunotherapy Cell Therapy Clinical Medicine Immune System Immunotherapy Solid Tumors Biotechnology Cancer Treatment Tumors Of The Hematopoietic And Lymphoid Tissues Virotherapy Breast And Lung Cancer Cancer Immunotherapy Product Chimeric Antigen Receptor Hematological Malignancies Immunotherapy Products Melanoma Multiple Myeloma

    Related ETFs - A few ETFs which own one or more of the above listed Adoptive Cell Transfer stocks.

    Symbol Grade Name Weight
    CNCR D Loncar Cancer Immunotherapy ETF 4.27
    IDNA C iShares Genomics Immunology and Healthcare ETF 3.3
    WDNA D WisdomTree BioRevolution Fund 3.24
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 3.07
    MOON F Direxion Moonshot Innovators ETF 2.56
    View all Adoptive Cell Transfer ETFs...
    Compare ETFs
    Compare CNCR to IDNA Compare WDNA to BBC Compare WDNA to MOON

        Adoptive Cell Transfer Stocks Recent News

        Date Stock Title
        May 16 IOVA 4 Small-Cap Value Stocks That Could Go Parabolic
        May 15 ADAP Adaptimmune Therapeutics plc (ADAP) Q1 2024 Earnings Call Transcript
        May 15 ALLO Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
        May 15 CERO CERo Therapeutics, Inc. Provides Corporate Update for Shareholders
        May 15 ADAP Adaptimmune GAAP EPS of -$0.03 beats by $0.04, revenue of $5.7M misses by $11.37M
        May 15 ADAP Adaptimmune Therapeutics gets $125M in financing from Hercules Capital
        May 15 ADAP Adaptimmune Reports Q1 2024 Financial and Business Updates
        May 15 ADAP Adaptimmune Secures up to $125 Million Debt Financing with Hercules Capital
        May 14 ACET Adicet Bio GAAP EPS of -$0.35
        May 14 ACET Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates
        May 14 ADAP Adaptimmune Q1 2024 Earnings Preview
        May 14 ALLO Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
        May 14 ACET Adicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid Congress
        May 14 IMTX Immatics reports Q1 results
        May 14 IMTX Immatics Announces First Quarter 2024 Financial Results and Business Update
        May 14 ALLO Allogene Therapeutics Inc (ALLO) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
        May 13 ALLO Allogene Therapeutics, Inc. (ALLO) Q1 2024 Earnings Call Transcript
        May 13 ALLO Allogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates
        May 13 ALLO Allogene Therapeutics announces pricing of $110M offering of common stock
        May 13 ALLO Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock
        Related Industries: Biotechnology Other
        Related Stock Lists: Cancer Medicine Biopharmaceutical Cancer Immunotherapy Cell Therapy Clinical Medicine Immune System Immunotherapy Solid Tumors Biotechnology Cancer Treatment Tumors Of The Hematopoietic And Lymphoid Tissues Virotherapy Breast And Lung Cancer Cancer Immunotherapy Product Chimeric Antigen Receptor Hematological Malignancies Immunotherapy Products Melanoma Multiple Myeloma
        Adoptive Cell Transfer

        Adoptive cell transfer (ACT) is a type of immunotherapy that involves taking immune cells from a patient, modifying them in the laboratory, and then infusing them back into the patient to help fight cancer. ACT works by boosting the patient’s own immune system to recognize and attack cancer cells. It is used to treat a variety of cancers, including melanoma, lymphoma, and leukemia.

        Browse All Tags